European Archives of Oto-Rhino-Laryngology

, Volume 271, Issue 1, pp 141–148 | Cite as

Pathological characteristics and clinical perspectives of papillary thyroid cancer: study of 714 patients

  • Davor DžepinaEmail author
  • Krešo Zurak
  • Vlado Petric
  • Hrvoje Čupić
Head and Neck


Papillary thyroid cancer belongs to most commonly diagnosed well-differentiated malignant tumor of the thyroid gland, with only minority of cases being more aggressive, recurring locoregionally and developing distant metastatic foci. The aim of this study was to determine the clinical relationship between parameters of age, gender, size of primary tumor, intraglandular dissemination and regional metastatic spread and evaluate the importance of each parameter; analyze other major aggressive factors (tumor border, thyroid capsule invasion, perivascular, perilymphatic spread) on prevalence and extent of intraglandular dissemination and relation to metastatic spread in neck. This study is a retrospective analysis of clinical and pathological data from 714 patients with papillary thyroid cancer, presented and operated at the Department of ENT/Head and Neck surgery, Sisters of Charity University Hospital, Zagreb, in the period from 1980 to 2008. All patients were operated upon with total thyroidectomy and some type of neck lymphonode dissection (paratracheal or lateral). In results, we found 46.9 % tumors were aggressive; 34.7 % tumors were multicentric, with foci in the contralateral lobe nearly twice as often as in the ipsilateral lobe; 27.8 % were regionally metastatic, with equal distribution between paratracheal and lateral regions. In conclusion, we revealed contralateral lobe multicentricity and male gender as independent risk factors for regional metastatic dissemination. Nodular goiter has been identified as a protective parameter.


Papillary thyroid cancer Multicentricity Regional metastasis Thyroidectomy Risk factors 




Ethical standard

All the research meets the ethics guidelines, including adherence to the legal requirements of the country where the study was performed.


  1. 1.
    Powell GJ, Hay ID (2003) Papillary carcinoma of the thyroid. In: Randolph GW (ed) Surgery of thyroid and parathyroid glands. WB Saunders, Philadelphia, pp 188–211Google Scholar
  2. 2.
    Yamashita H, Noguchi S, Yamashita H et al (1998) Changing trends and prognoses for patients with papillary thyroid cancer. Arch Surg 133:1058–1065PubMedCrossRefGoogle Scholar
  3. 3.
    Hundahl SA, Fleming ID, Fremgen AM et al (1998) A national cancer data base report on 53,856 cases of thyroid carcinoma treated in US 1985–1995. Cancer 83:2638–2648PubMedCrossRefGoogle Scholar
  4. 4.
    Zimmerman D, Hay ID, Gough IR et al (1988) Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 104:1157–1166PubMedGoogle Scholar
  5. 5.
    Palme CE, Waseem Z, Raza N et al (2004) Management and outcome of recurrent well differentiated thyroid carcinoma. Arch Otolaryngol Head Neck Surg 130:819–824PubMedCrossRefGoogle Scholar
  6. 6.
    Dinneen SF, Valimaki VJ, Bergstralh EJ et al (1995) Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 80:2041–2045PubMedCrossRefGoogle Scholar
  7. 7.
    Stojadinovic A, Shoup M, Nissan A et al (2002) Recurrent differentiated thyroid carcinoma: biological implications of age, method of detection, and site and extent of recurrence. Ann Surg Oncol 9:789–798PubMedCrossRefGoogle Scholar
  8. 8.
    Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428PubMedCrossRefGoogle Scholar
  9. 9.
    Passler C, Prager G, Scheuba C et al (2003) Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch Surg 138:1362–1366PubMedCrossRefGoogle Scholar
  10. 10.
    Chow SM, Chan JK, Law SC et al (2003) Diffuse sclerosing variant of papillary thyroid carcinoma—clinical features and outcome. Eur J Surg Oncol 29:446–449PubMedCrossRefGoogle Scholar
  11. 11.
    Carcangiu ML, Bianchi S (1989) Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol 13:1041–1049PubMedCrossRefGoogle Scholar
  12. 12.
    Michels JJ, Jacques MJ, Henry-Amar M et al (2007) Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Hum Pathol 38:212–219PubMedCrossRefGoogle Scholar
  13. 13.
    Ostrowski ML, Merino MJ (1996) Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid gland. Am J Surg Pathol 20:964–974PubMedCrossRefGoogle Scholar
  14. 14.
    Berho M, Suster S (1997) The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol 28:47–53PubMedCrossRefGoogle Scholar
  15. 15.
    Urano M, Abe M, Kuroda M et al (2001) Warthin-like tumor variant of papillary thyroid carcinoma: case report and literature review. Pathol Int 51:707–712PubMedCrossRefGoogle Scholar
  16. 16.
    Akslen LA, LiVolsi VA (2000) Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer 88:1902–1908PubMedCrossRefGoogle Scholar
  17. 17.
    Sherman SI et al (1998) Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. Cancer 83:1012–1021PubMedCrossRefGoogle Scholar
  18. 18.
    Sebastian SO et al (2000) Papillary thyroid carcinoma; prognostic index for survival including the histological variety. Arch Surg 135:272–277PubMedCrossRefGoogle Scholar
  19. 19.
    Lang BH, Lo CY, Chan WF et al (2007) Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg 245:366–378PubMedCrossRefGoogle Scholar
  20. 20.
    Shaha AR, Shah JP, Loree TR (1997) Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol 4:328–333PubMedCrossRefGoogle Scholar
  21. 21.
    National Comprehensive Cancer Network (NCCN) (2007) Thyroid cancer clinical practice guidelines in oncology. J compr cancer netw
  22. 22.
    Loh K-C, Greenspan FS, Gee L et al (1997) Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 82:3553–3562PubMedCrossRefGoogle Scholar
  23. 23.
    Brierley JD, Panzarella T, Tsang RW et al (1997) A comparison of different staging systems predictability of patient outcome: thyroid carcinoma as an example. Cancer 79:2414–2423PubMedCrossRefGoogle Scholar
  24. 24.
    Udelsman R, Lakatos E, Ladenson P (1996) Optimal surgery for papillary thyroid carcinoma. World J Surg 20:88–93PubMedCrossRefGoogle Scholar
  25. 25.
    Esnaola NF, Cantor SB, Sherman SI et al (2001) Optimal treatment strategies in patients with papillary thyroid cancer: a decision analysis. Surgery 130:921–930PubMedCrossRefGoogle Scholar
  26. 26.
    Gardner RE, Tuttle RM, Burman KD et al (2000) Prognostic importance of vascular invasion in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 126:309–312PubMedCrossRefGoogle Scholar
  27. 27.
    Robbins KT, Shaha AR, Medina JE et al (2008) Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134:536–538PubMedCrossRefGoogle Scholar
  28. 28.
    Kusic Z, Jukic T, Franceschi M et al (2009) Croatian thyroid society guidelines for rational detection of thyroid dysfunction. Lijec Vjesn 131:328–338PubMedGoogle Scholar
  29. 29.
    Shaha AR (2004) Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Surgery 135:237–239PubMedCrossRefGoogle Scholar
  30. 30.
    Lo CY, Chan WF, Lam KY et al (2004) Optimizing the treatment of AMES high-risk papillary thyroid carcinoma. World J Surg 28:1103–1109PubMedCrossRefGoogle Scholar
  31. 31.
    Tyler DS, Shaha AR, Udelsman RA et al (2000) Thyroid cancer: 1999 update. Ann Surg Oncol 7:376–398PubMedCrossRefGoogle Scholar
  32. 32.
    Cheema Y, Olson S, Elson D et al (2006) What is the biology and optimal treatment for papillary microcarcinoma of the thyroid? J Surg Res 134:160–162PubMedCrossRefGoogle Scholar
  33. 33.
    Pellegriti G, Scollo C, Lumera G et al (2004) Clinical behaviour and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 Cases. J Clin Endocrinol Metab 89:3713–3720PubMedCrossRefGoogle Scholar
  34. 34.
    McCarthy RP et al (2006) Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas. Clin Cancer Res. 12:2414–2418PubMedCrossRefGoogle Scholar
  35. 35.
    Shattuck TM, Westra WH, Ladenson PW et al (2005) Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med 352:2406–2412PubMedCrossRefGoogle Scholar
  36. 36.
    Sugg SL, Ezzat S, Rosen IB et al (1998) Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 83:4116–4122PubMedCrossRefGoogle Scholar
  37. 37.
    Chow SM, Law SCK, Chan JKC et al (2003) Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality. Cancer 98:31–40PubMedCrossRefGoogle Scholar
  38. 38.
    Clark RL Jr, White EC, Russel WO (1959) Total thyreoidectomy for cancer of the thyroid: significance of intraglandular dissemination. Ann Surg 149:858–866PubMedCrossRefGoogle Scholar
  39. 39.
    Leboullex S, Rubino C, Baudin E et al (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723–5729CrossRefGoogle Scholar
  40. 40.
    Grigsby PW, Reddy RM, Moley JF et al (2006) Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment. Surgery 140:1043–1049PubMedCrossRefGoogle Scholar
  41. 41.
    Lion JD, Chao TC, Hsueh C et al (2009) High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol 16:2609–2616CrossRefGoogle Scholar
  42. 42.
    Baudin E, Travagli JP, Ropers J et al (1998) Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83:553–559PubMedCrossRefGoogle Scholar
  43. 43.
    Wang TS, Dubner S, Sznyter LA et al (2004) Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes. Arch Otolaryngol Head Neck Surg 130:110–113PubMedCrossRefGoogle Scholar
  44. 44.
    Mirralie E, Visset J, Sagan C et al (1999) Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 23:970–973CrossRefGoogle Scholar
  45. 45.
    Harach HR, Fransilla KO, Wasenius V (1985) Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer 56:531–538PubMedCrossRefGoogle Scholar
  46. 46.
    Bramley MD, Harrison BJ (1996) Papillary microcarcinoma of the thyroid gland. Br J Surg 83:1674–1683PubMedCrossRefGoogle Scholar
  47. 47.
    Cooper DS, Doherty GM, Haugen BR et al (2006) The American thyroid association guidelines taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142PubMedCrossRefGoogle Scholar
  48. 48.
    Noguchi S, Noguchi A, Murakami N (1970) Papillary carcinoma of the thyroid I: developing pattern of metastases. Cancer 26:1053–1060PubMedCrossRefGoogle Scholar
  49. 49.
    Machens A, Holzhausen H-J, Dralle H (2004) Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 139:43–45PubMedCrossRefGoogle Scholar
  50. 50.
    Pingpank JF Jr, Sasson AR, Hanlon AL et al (2002) Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes. Arch Otolaryngol Head Neck Surg 128:1275–1278PubMedCrossRefGoogle Scholar
  51. 51.
    Monchik JM, De Petris G, De Crea C (2001) Occult papillary carcinoma of the thyroid presenting as a cervical cyst. Surgery 129:429–432PubMedGoogle Scholar
  52. 52.
    Massin JP, Savoie JC, Garnier H et al (1984) Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer 53:982–992PubMedCrossRefGoogle Scholar
  53. 53.
    Hay ID, Bergstralh EJ, Goellner JR et al (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050–1058PubMedGoogle Scholar
  54. 54.
    Cady B (1998) Staging in thyroid carcinoma. Cancer 83:844–847PubMedCrossRefGoogle Scholar
  55. 55.
    Sato N, Oyamatsu M, Koyama Y et al (1998) Do the level of nodal disease according to TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 69:151–155PubMedCrossRefGoogle Scholar
  56. 56.
    Tsang RW, Brierley JD, Simpson EJ et al (1998) The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 83:1012–1021CrossRefGoogle Scholar
  57. 57.
    Yamashita H, Noguchi S, Murakami N et al (1999) Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer 86:842–849PubMedCrossRefGoogle Scholar
  58. 58.
    Sellers M, Beenken S, Blankenship A et al (1992) Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg 164:578–581PubMedCrossRefGoogle Scholar
  59. 59.
    Casara D, Rubello D, Saladini G et al (1993) Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 34:1626–1631PubMedGoogle Scholar
  60. 60.
    Beasley NJP, Lee J, Eski S et al (2002) Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 128:825–828PubMedCrossRefGoogle Scholar
  61. 61.
    Shindo M, Wu JC, Park EE, Tanzella F (2006) The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 132:650–654PubMedCrossRefGoogle Scholar
  62. 62.
    Vassilopoulou-Selin R, Schultz PN, Haynie TP (1996) Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 78:439–501Google Scholar
  63. 63.
    Simon D, Goretzki PE, Witte J et al (1996) Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 20:860–866PubMedCrossRefGoogle Scholar
  64. 64.
    Grant CS, Hay ID, Gough IR et al (1988) Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 104:954–962PubMedGoogle Scholar
  65. 65.
    Hay ID et al (1998) Unilateral total lobectomy: is it sufficient surgical treatment for patient with AMES low-risk papillary thyroid carcinoma? Surgery 124:958–966PubMedCrossRefGoogle Scholar
  66. 66.
    Cady B (1997) Our AMES is true: how an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 174:462–468PubMedCrossRefGoogle Scholar
  67. 67.
    Grebe SK, Hay ID (1996) Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin North Am 5:43–63Google Scholar
  68. 68.
    Gemsenjäger E, Heitz PU, Martina B (1997) Selective treatment of thyroid carcinoma. World J Surg 21:546–552PubMedCrossRefGoogle Scholar
  69. 69.
    Sanders LE, Cady B (1998) Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 133:419–425PubMedCrossRefGoogle Scholar
  70. 70.
    Farrar WB, Cooperman M, James AG (1980) Surgical management of papillary and follicular carcinoma of thyroid. Ann Surg 192:701–704PubMedCrossRefGoogle Scholar
  71. 71.
    Wanebo HJ, Andrews W, Kaiser DL (1981) Thyroid cancer: some basic considerations. Am J Surg 142:472–479CrossRefGoogle Scholar
  72. 72.
    Mazzaferi EL, Young RL (1981) Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70:511–518CrossRefGoogle Scholar
  73. 73.
    Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:1–33CrossRefGoogle Scholar
  74. 74.
    Grodski S, Delbridge L (2009) An update on papillary microcarcinoma. Curr Opin Oncol 21:1–4PubMedCrossRefGoogle Scholar
  75. 75.
    The American thyroid association guidelines taskforce (2006) The American guidelines for patients with thyroid nodules and differentiated cancer. Thyroid 16(2); 109–42Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Davor Džepina
    • 1
    Email author
  • Krešo Zurak
    • 1
  • Vlado Petric
    • 1
    • 3
  • Hrvoje Čupić
    • 2
    • 3
  1. 1.Department of ENT, Head and Neck SurgeryUniversity Clinical Hospital Center Sisters of CharityZagrebCroatia
  2. 2.Department of PathologyUniversity Clinical Hospital Center Sisters of CharityZagrebCroatia
  3. 3.Zagreb University School of MedicineZagrebCroatia

Personalised recommendations